Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06458959 · ClinicalTrials.gov registry record · NA

Exploratory Trial of a Pediatric Web-Based Care Planning Guide

A NA study of Developmental Delay and Developmental Disabilities, sponsored by University of Illinois at Chicago.

Active
Registry status
NA
Development phase
223
Enrollment target
1
Study location

NCT06458959: Active NA study of Developmental Delay and Developmental Disabilities, sponsored by University of Illinois at Chicago.

NCT06458959 is a NA study of Developmental Delay and Developmental Disabilities that is active but no longer recruiting, run by University of Illinois at Chicago. The registered enrollment target is 223 participants, below the 275-participant average among 10 other Developmental Delay trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06458959, a NA study of Developmental Delay and Developmental Disabilities, is active but no longer recruiting, sponsored by University of Illinois at Chicago.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
223 participants
Enrollment target
1
Study location

Study Summary

Infants and toddlers with developmental disabilities or delays use early intervention (EI) for rehabilitation services. Yet, poor quality of EI services is pervasive, particularly for racially and ethnically diverse and socially disadvantaged families. A key lever to improve EI quality is family-centered care, an evidence-based approach that is grounded in family engagement for shared decision-making. This project is motivated by the need to give families a smart and connected option for engaging in the design of the EI service plan for their child. This project upgrades and tests an evidence-based and innovative electronic solution that helps families to organize and share their priorities for change and ideas for goal attainment with professionals, so as to ensure fit of the service plan with their needs.

Interventions

  • BEHAVIORAL PEM+

Study Locations (1)

Illinois

  • University of Illinois Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 223 participants
Start Date 2024-12-12
Est. Completion 2025-09-30
Phase NA
University of Illinois at Chicago

430 total trials

What the registry record for NCT06458959 still lists

NCT06458959 is an interventional study that assigns participants to a tested intervention. The registered 223 participants enrollment target is mid-sized for trials with a published cap, below the 275-participant average among 10 other Developmental Delay trials with a reported enrollment target (19% lower).

The record links to 2 conditions, with Developmental Delay appearing as the primary indexed condition, and to 1 intervention - of which PEM+ is the first listed.

NCT06458959 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT06458959 about?

NCT06458959 is a clinical study titled "Exploratory Trial of a Pediatric Web-Based Care Planning Guide". Infants and toddlers with developmental disabilities or delays use early intervention (EI) for rehabilitation services. Yet, poor quality of EI services is pervasive, particularly for racially and ethnically diverse and socially disadvantaged families. A key lever to improve EI quality is family-cen...

What is the current status of trial NCT06458959?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 223 participants. The study started on 2024-12-12. Estimated completion is 2025-09-30.

What conditions does trial NCT06458959 study?

This clinical trial studies the following conditions: Developmental Delay, Developmental Disabilities.

What interventions are being tested in trial NCT06458959?

The interventions under investigation include: PEM+ (BEHAVIORAL).

Who is sponsoring clinical trial NCT06458959?

This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06458959 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Developmental Delay

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06458959's enrollment target sits among peer trials

223 6th of 10 higher than 5 of 10 other Developmental Delay trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Developmental Delay trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06640803 · 223 participants · NA

    Sacramento Clinical High Risk for Psychosis Stepped-Care Program

  • NCT07175285 · 223 participants

    A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

  • NCT07205718 · 223 participants · Phase 1

    A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

  • NCT02706561 · 224 participants · NA

    Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06458959, the US trial registry maintained by the National Library of Medicine. NCT06458959 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.